Litva - litavski - SMCA (Valstybinė vaistų kontrolės tarnyba)

dompe farmaceutici s.p.a - ketoprofenas - dengtos granulės paketėlyje - 25 mg - ketoprofen

Litva - litavski - SMCA (Valstybinė vaistų kontrolės tarnyba)

elme messer lit, uab - diazoto oksidas/deguonis - suslėgtosios medicininės dujos - 50 %/50 % - nitrous oxide, combinations

Litva - litavski - SMCA (Valstybinė vaistų kontrolės tarnyba)

sandoz d.d. - budezonidas/formoterolio fumaratas dihidratas - dozuoti įkvepiamieji milteliai - 320 µg/9 µg - formoterol and budesonide

Europska Unija - litavski - EMA (European Medicines Agency)

samsung bioepis nl b.v. - ranibizumabas - wet macular degeneration; macular edema; diabetic retinopathy; myopia, degenerative - oftalmologai - byooviz is indicated in adults for:the treatment of neovascular (wet) age-related macular degeneration (amd)the treatment of visual impairment due to diabetic macular oedema (dme)the treatment of proliferative diabetic retinopathy (pdr)the treatment of visual impairment due to macular oedema secondary to retinal vein occlusion (branch rvo or central rvo)the treatment of visual impairment due to choroidal neovascularisation (cnv).

Litva - litavski - SMCA (Valstybinė vaistų kontrolės tarnyba)

fairmed healthcare gmbh - levodopa/karbidopa - tabletės - 100 mg/25 mg - levodopa and decarboxylase inhibitor

Litva - litavski - SMCA (Valstybinė vaistų kontrolės tarnyba)

fairmed healthcare gmbh - levodopa/karbidopa - tabletės - 250 mg/25 mg - levodopa and decarboxylase inhibitor

Litva - litavski - SMCA (Valstybinė vaistų kontrolės tarnyba)

stada arzneimittel ag - bortezomibas - injekcinis tirpalas - 2,5 mg/ml - bortezomib

Europska Unija - litavski - EMA (European Medicines Agency)

stada arzneimittel ag - ranibizumabas - wet macular degeneration; macular edema; diabetic retinopathy; diabetes complications - oftalmologai - ximluci is indicated in adults for:the treatment of neovascular (wet) age-related macular degeneration (amd)the treatment of visual impairment due to diabetic macular oedema (dme)the treatment of proliferative diabetic retinopathy (pdr)the treatment of visual impairment due to macular oedema secondary to retinal vein occlusion (branch rvo or central rvo)the treatment of visual impairment due to choroidal neovascularisation (cnv).

Europska Unija - litavski - EMA (European Medicines Agency)

roche registration gmbh - faricimab - wet macular degeneration; macular edema; diabetes complications - oftalmologai - vabysmo is indicated for the treatment of adult patients with:neovascular (wet) age-related macular degeneration (namd),visual impairment due to diabetic macular oedema (dme).

Europska Unija - litavski - EMA (European Medicines Agency)

midas pharma gmbh - ranibizumabas - wet macular degeneration; macular edema; diabetic retinopathy; diabetes complications - oftalmologai - ranivisio is indicated in adults for:• the treatment of neovascular (wet) age-related macular degeneration (amd)• the treatment of visual impairment due to diabetic macular oedema (dme)• the treatment of proliferative diabetic retinopathy (pdr)• the treatment of visual impairment due to macular oedema secondary to retinal vein occlusion (branch rvo or central rvo)• the treatment of visual impairment due to choroidal neovascularisation (cnv).